Description
| Specialty | COARAVEN | 
|---|---|
| Dosage | 25 mg, 300 mg | 
| Form | Film-coated tablet | 
| Presentation | Box of 90 | 
| Primary Packaging | Blister | 
| Specification | Opaque white PVC/PVDC/Alu | 
| INN | HYDROCHLOROTHIAZIDE, IRBESARTAN | 
| VEIC Classification | Essential | 
| Therapeutic Class | CARDIOVASCULAR SYSTEM | 
| Sub-Class | Agents Acting on the Renin-Angiotensin System | 
| Laboratory | PHILADELPHIA PHARMA | 
| Schedule | A | 
| Shelf Life | 24 months | 
| Generic/Reference | Generic | 
| Marketing Authorization (MA) | 93530410 | 
| MA Date | 2014-08-12 | 
| Range | Cardio-Metabolic Range | 







Reviews
There are no reviews yet.